Given the staining observed, their significant subcellular staining locations and their involvement in signalling pathways, including TGF-β and Hippo identified via KEGG analysis, STK3 and BAMBI are promising biomarkers and targets for future OSA therapies. The gene discussed is STK3; the disease is obstructive sleep apnea syndrome.